Bubela T - Search Results

1

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement.

Bubela T, McCabe C, Archibald P, Atkins H, Bradshaw SE, Kefalas P, Mujoomdar M, Packer C, Piret J, Raxworthy M, Soares M, Viswanathan S. Bubela T, et al. Regen Med. 2015;10(7):897-911. doi: 10.2217/rme.15.51. Epub 2015 Nov 13. Regen Med. 2015. PMID: 26565607 Free article. Review.

2

The global landscape of stem cell clinical trials.

Li MD, Atkins H, Bubela T. Li MD, et al. Among authors: bubela t. Regen Med. 2014 Jan;9(1):27-39. doi: 10.2217/rme.13.80. Epub 2013 Nov 18. Regen Med. 2014. PMID: 24236476 Free article.

3

Value-engineered translation for regenerative medicine: meeting the needs of health systems.

Bubela T, McCabe C. Bubela T, et al. Stem Cells Dev. 2013 Dec;22 Suppl 1(Suppl 1):89-93. doi: 10.1089/scd.2013.0398. Stem Cells Dev. 2013. PMID: 24304083 Free PMC article.

4

Current practices and reform proposals for the regulation of advanced medicinal products in Canada.

Viswanathan S, Bubela T. Viswanathan S, et al. Among authors: bubela t. Regen Med. 2015;10(5):647-63. doi: 10.2217/rme.15.28. Regen Med. 2015. PMID: 26237706 Free article. Review.

5

Is belief larger than fact: expectations, optimism and reality for translational stem cell research.

Bubela T, Li MD, Hafez M, Bieber M, Atkins H. Bubela T, et al. BMC Med. 2012 Nov 6;10:133. doi: 10.1186/1741-7015-10-133. BMC Med. 2012. PMID: 23131007 Free PMC article.

6

The Importance of and Challenges with Adopting Life-Cycle Regulation and Reimbursement in Canada.

McPhail M, McCabe C, Regier DA, Bubela T. McPhail M, et al. Among authors: bubela t. Healthc Policy. 2022 Feb;17(3):81-90. doi: 10.12927/hcpol.2022.26726. Healthc Policy. 2022. PMID: 35319446 Free PMC article.

7

Value-engineered translation: developing biotherapeutics that align with health-system needs.

Bubela T, McCabe C. Bubela T, et al. Am J Manag Care. 2014 Jul;20(10 Spec No):E3. Am J Manag Care. 2014. PMID: 25830190 No abstract available.

8

Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada.

Bubela T, Boch R, Viswanathan S. Bubela T, et al. Front Med (Lausanne). 2019 Mar 28;6:58. doi: 10.3389/fmed.2019.00058. eCollection 2019. Front Med (Lausanne). 2019. PMID: 30984761 Free PMC article.

9

Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation.

Bubela T, Reshef A, Li MD, Atkins H, Caulfield T, Culme-Seymour E, Gold ER, Illes J, Isasi R, McCabe C, Ogbogu U, Piret J, Mason C. Bubela T, et al. Regen Med. 2012 Nov;7(6):735-40. doi: 10.2217/rme.12.59. Epub 2012 Oct 1. Regen Med. 2012. PMID: 23020169 No abstract available.

10

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.

Fung M, Yuan Y, Atkins H, Shi Q, Bubela T. Fung M, et al. Among authors: bubela t. Stem Cell Reports. 2017 May 9;8(5):1190-1201. doi: 10.1016/j.stemcr.2017.03.013. Epub 2017 Apr 13. Stem Cell Reports. 2017. PMID: 28416287 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters